Finished Dosage Forms

Finished Dosage Forms Companies (397)

Finished Dosage Forms News

Finished Dosage Forms Products (1000+)

  • Product Valetra 20mg _Vardenafil Tablets 20mg

    Valetra 20mg contains API Vardenafil, which  is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men. Vardenafil is in a class of medications called phosphodiesterase (PDE) inhibitors. It works by increasing blood flow to the penis during sexual stimulation. ...
  • Product Rolon 250 - Nandrolone Decanoate Injection USP

    Shree Venkatesh International Ltd is offering Rolon 250mg which is having the drug ingredient called Nandrolone Decanoate 250mg. Contact us for more Information.
  • Product Colistimethate sodium lyophilized vials

    Colistimethate sodium is a prodrug of colistin, which is a mixture of polypeptide antibiotics active against Gram-negative bacteria, including Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae and especially Pseudomonas aeruginosa.

    Indication:&nbs...
  • Product Daptomycin vials

    Daptomycin is a lipopeptide antibacterial agent active against Gram-positive bacteria.

    Indication: Used in the treatment of complicated skin and skin structure/soft-tissue infections caused by susceptible isolates of Gram-positive bacteria such as Staphylococcus au...
  • Product Bioavailability Enhancement - Oral Drug Products and Intermediates

    The depth of our bioavailability (BA) enhancement offering makes us a leader in addressing addressing low solubility, low bioavailability and dissolution rate issues. We work collaboratively with our customers to advance compounds, or re-purpose existing compounds, across a full range of API properties and...
  • Product Broncositol® oral supplement

    The only myo-inositol-based dietary supplement specifically designed to manage respiratory diseases   
    Supports the maintenance of the physiological state of the respiratory system by promoting the health of mucous membranes and the production of lung surfactants 


    The inclu...
  • Product Sterile drug product CDMO services

    Thermo Fisher Scientific's flexible aseptic manufacturing and sterile fill finish solutions for your molecule’s unique needs and challenges will enable success in early development, late-phase, and commercial manufacturing.

    Thermo Fisher offers extensive sterile product development and commercial ...
  • Product Out Licensing Dossiers

    • Out Licensing • Technology Transfer • Co-Development / Profit Sharing with •
    Technology Partners

    API partners

    Marketing Partners

    CMO Partners


  • Product Inofolic ® & Inofolic ® HP

    A breakthrough in the managementof PCOS and female infertility
    • Pharmaceutical form: Sachets | Soft-gel caps • Clinical trials: Efficacy of the product line is supported by 60+ international clinical trials in more than 5000 patients. Many published studies demonstrate efficacy in imp...
  • Product Bactamed i.m / intravenously

    World medicine offers wide range of pharmaceutical products which includes bactamed i.m / intravenously. It belongs to systemic use of anti-infectives products category. Active substance: sulbaktam sodyum steril, ampisilin sodyum steri.
  • Product Bactamed i.m

    World medicine offers wide range of pharmaceutical products which includes bactamed i.m. It belongs to systemic use of anti-infectives products category. Active substance: sulbaktam sodyum steril, ampisilin sodyum steri.
  • Product Pharmaceutical Development Services

    Patheon enables its customers to bring drug candidates from preclinical stages through to clinical trials, the NDA approval process and, if approved, commercial manufacturing. Patheon offers the full breadth of advanced scientific and preformulation services through to late development in solid and sterile...
  • Product Xerthra™ kits

    Xerthra™ kits – procedure packs for isolation and separation of platelet rich plasma (PRP) or injectible fibrine (iPRF) from patient’s peripheral blood.
    Xerthra™ PRP kit provides  a fraction of autologus plasma with increased number of leukocytes which synthesize cytokines and higher amounts ...
  • Product DEFENSES

    EFICAPS® DEFENSES (+12 years): To contribute to normal function of the immune system and to the protection of cells from oxidative stress.

    Contains Vitamin D3 50 μg (2000 IU), selenium, zinc and Echinacea angustifolia extract.

    ...
  • Product Scientific Support

    Selectchemie AG provides a wide range of services including scientific support. Our experienced professionals are at your service at locations in 18 countries to deliver tailor-made solutions according to your needs. Contact us for more information.
  • Product POSAKSIN ORAL SUSPENSION

    POSACONAZOLE 40 MG/ML ORAL SUSPENSION (105 ML BOTTLE)
  • Product CordenPharma Oral Formulation Tablets & Capsule Drug Products

    CordenPharma’s service offerings include a wide range of products, formulations and services supporting new chemical entities, re-formulations and generics:
    • Powder & Granule-filled Capsules • Powder Granules & Pellets • Immediate Release Tablets • Controlled Release Tablets • Mini-tablets...
  • Product Beelixir™

    Beelixir™ with its unique ROYAL YOUTH™ formula – a standardised combination of royal jelly, nicotinamide adenine dinucleotide (NAD) and Q10 coenzyme with zinc and vitamins D3 and B1 – offers an efficient approach to ageing cells. It supports cellular functions and helps slow down biological ageing.

    ...
  • Product Pycnogenol® Vein Support

    Pycnogenol® is a purely herbal product with 80 mg of patented French maritime pine bark extract. 
    Pycnogenol® is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, biof...
Find your finished dosage forms suppliers online: our directory lists nearly 500 suppliers offering 2,500+ products that range from creams and capsules to powders, sprays, suspensions and more.

Finished Dosage Formulation

A Finished Dosage Form is a finished drug product resulting from Finished Dosage Formulation (FDF), the various processes involved in production such as manufacturing, testing, and subsequent approval for consumption and delivery to the public.

Active Pharmaceutical Ingredients (API’s), responsible for the results the user gets after taking the dosage forms, are involved in the FDF along with inactive ingredients (excipients) which serve as a medium for the active ingredients to function.

FDF is a critical stage in the product lifecycle and can only be achieved if the manufacturing facility of a pharmaceutical company or Contract Manufacturing Organization is up to a high-end standard. This is a major reason why some companies are into out-licensing since they don’t have the standard manufacturing facility to produce the dosage forms.

Processes Involved in Finished Dosage Formulation Development

The processes involved here are quite complex. Analysis comes first involving the active pharmaceutical ingredients and excipients. A compatibility study is also done between them.

Next is the formulation development which includes the definition of quantitative and qualitative formulas, formulating the manufacturing method, and establishment of in-process controls.

The next process is the main manufacturing process, which then proceeds to quality control, clinical trials, stability studies and manufacturing regulations before the drug product is transferred to the client if it’s been conducted by a pharmaceutical contract manufacturing organization.

What are the Benefits of Outsourcing Finished Dosage Formulation Development?

Formulation development is an integral process for any commercial manufacturing pharma company and even for private purposes in the development of solid dosage forms. This is why outsourcing always comes in handy because the pharmaceutical contract manufacturing firms are usually more equipped with state-of-the-art manufacturing equipment.

They also ensure that the drug product meets the required industry benchmark using the right method development and standard clinical trial materials to ensure there are no loopholes.

Overall, outsourcing ensures that the dosage form is up to the best standard and is duly regulated.

Growth in Finished Dosage Formulations Market

The key factors that are driving trends in the finished dosage formulation market are:

• Access to cutting-edge technological resources in the global pharmaceutical industry.

• An increased need to outsource drug development and pharmaceutical contract manufacturing.

• The increasing contract manufacturing market share of the industry.



Laws and Regulations for the Manufacture of Finished Dosage Formulation

The US FDA’s Current Good Manufacturing Practice regulations require three successful full-scale batches of finished dosage formulation. These three validation batches are essential to ensure that process design and development studies are up to the required standard for active pharmaceutical ingredients, excipients, and drug production generally. GMP compliance is vital to acquire a license to manufacture finished dosage formulations like soft gelatin capsules.



References

Upcoming Events

  • CPHI Barcelona 2023

    Fira Barcelona Gran Via, Spain
    24-26 October 2023